The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sintilimab Injection Market Research Report 2025
Synopsis
Sintilimab, marketed as TYVYT® (sintilimab injection) in China, is a PD-1 immunoglobulin G4 monoclonal antibody co-developed by Innovent and Eli Lilly and Company. Sintilimab is a type of immunoglobulin G4 monoclonal antibody, which binds to PD-1 molecules on the surface of T-cells, blocks the PD-1 / PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells. Innovent is currently conducting more than 20 clinical studies of sintilimab to evaluate its safety and efficacy in a wide variety of cancer indications, including more than 10 registrational or pivotal clinical trials.
Global Sintilimab Injection market is projected to reach US$ 230.7 million in 2029, increasing from US$ 142 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sintilimab Injection market research.
Key manufacturers engaged in the Sintilimab Injection industry include Innovant Biologics, Inc.. etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sintilimab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sintilimab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sintilimab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Innovant Biologics, Inc.
Segment by Type
100mg/10ml
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sintilimab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Sintilimab, marketed as TYVYT® (sintilimab injection) in China, is a PD-1 immunoglobulin G4 monoclonal antibody co-developed by Innovent and Eli Lilly and Company. Sintilimab is a type of immunoglobulin G4 monoclonal antibody, which binds to PD-1 molecules on the surface of T-cells, blocks the PD-1 / PD-Ligand 1 (PD-L1) pathway, and reactivates T-cells to kill cancer cells. Innovent is currently conducting more than 20 clinical studies of sintilimab to evaluate its safety and efficacy in a wide variety of cancer indications, including more than 10 registrational or pivotal clinical trials.
Global Sintilimab Injection market is projected to reach US$ 230.7 million in 2029, increasing from US$ 142 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sintilimab Injection market research.
Key manufacturers engaged in the Sintilimab Injection industry include Innovant Biologics, Inc.. etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Sintilimab Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Sintilimab Injection market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sintilimab Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Innovant Biologics, Inc.
Segment by Type
100mg/10ml
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sintilimab Injection report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Sintilimab Injection Market Overview
1.1 Product Overview and Scope of Sintilimab Injection
1.2 Sintilimab Injection Segment by Type
1.2.1 Global Sintilimab Injection Market Value Comparison by Type (2023-2029)
1.2.2 100mg/10ml
1.2.3 Others
1.3 Sintilimab Injection Segment by Application
1.3.1 Global Sintilimab Injection Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Sintilimab Injection Market Size Estimates and Forecasts
1.4.1 Global Sintilimab Injection Revenue 2018-2029
1.4.2 Global Sintilimab Injection Sales 2018-2029
1.4.3 Global Sintilimab Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sintilimab Injection Market Competition by Manufacturers
2.1 Global Sintilimab Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sintilimab Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sintilimab Injection Average Price by Manufacturers (2018-2023)
2.4 Global Sintilimab Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sintilimab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sintilimab Injection, Product Type & Application
2.7 Sintilimab Injection Market Competitive Situation and Trends
2.7.1 Sintilimab Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sintilimab Injection Players Market Share by Revenue
2.7.3 Global Sintilimab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sintilimab Injection Retrospective Market Scenario by Region
3.1 Global Sintilimab Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sintilimab Injection Global Sintilimab Injection Sales by Region: 2018-2029
3.2.1 Global Sintilimab Injection Sales by Region: 2018-2023
3.2.2 Global Sintilimab Injection Sales by Region: 2024-2029
3.3 Global Sintilimab Injection Global Sintilimab Injection Revenue by Region: 2018-2029
3.3.1 Global Sintilimab Injection Revenue by Region: 2018-2023
3.3.2 Global Sintilimab Injection Revenue by Region: 2024-2029
3.4 North America Sintilimab Injection Market Facts & Figures by Country
3.4.1 North America Sintilimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sintilimab Injection Sales by Country (2018-2029)
3.4.3 North America Sintilimab Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sintilimab Injection Market Facts & Figures by Country
3.5.1 Europe Sintilimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sintilimab Injection Sales by Country (2018-2029)
3.5.3 Europe Sintilimab Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sintilimab Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Sintilimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sintilimab Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Sintilimab Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sintilimab Injection Market Facts & Figures by Country
3.7.1 Latin America Sintilimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sintilimab Injection Sales by Country (2018-2029)
3.7.3 Latin America Sintilimab Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sintilimab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Sintilimab Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sintilimab Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sintilimab Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sintilimab Injection Sales by Type (2018-2029)
4.1.1 Global Sintilimab Injection Sales by Type (2018-2023)
4.1.2 Global Sintilimab Injection Sales by Type (2024-2029)
4.1.3 Global Sintilimab Injection Sales Market Share by Type (2018-2029)
4.2 Global Sintilimab Injection Revenue by Type (2018-2029)
4.2.1 Global Sintilimab Injection Revenue by Type (2018-2023)
4.2.2 Global Sintilimab Injection Revenue by Type (2024-2029)
4.2.3 Global Sintilimab Injection Revenue Market Share by Type (2018-2029)
4.3 Global Sintilimab Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sintilimab Injection Sales by Application (2018-2029)
5.1.1 Global Sintilimab Injection Sales by Application (2018-2023)
5.1.2 Global Sintilimab Injection Sales by Application (2024-2029)
5.1.3 Global Sintilimab Injection Sales Market Share by Application (2018-2029)
5.2 Global Sintilimab Injection Revenue by Application (2018-2029)
5.2.1 Global Sintilimab Injection Revenue by Application (2018-2023)
5.2.2 Global Sintilimab Injection Revenue by Application (2024-2029)
5.2.3 Global Sintilimab Injection Revenue Market Share by Application (2018-2029)
5.3 Global Sintilimab Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Innovant Biologics, Inc.
6.1.1 Innovant Biologics, Inc. Corporation Information
6.1.2 Innovant Biologics, Inc. Description and Business Overview
6.1.3 Innovant Biologics, Inc. Sintilimab Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Innovant Biologics, Inc. Sintilimab Injection Product Portfolio
6.1.5 Innovant Biologics, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sintilimab Injection Industry Chain Analysis
7.2 Sintilimab Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sintilimab Injection Production Mode & Process
7.4 Sintilimab Injection Sales and Marketing
7.4.1 Sintilimab Injection Sales Channels
7.4.2 Sintilimab Injection Distributors
7.5 Sintilimab Injection Customers
8 Sintilimab Injection Market Dynamics
8.1 Sintilimab Injection Industry Trends
8.2 Sintilimab Injection Market Drivers
8.3 Sintilimab Injection Market Challenges
8.4 Sintilimab Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
